No Detail Found!

Comparison of the efects of losartan potassium and benazepril in the treatment of hypertensive patients with insulin resistance

Author(s)
Tingting Ma Department of General Practice, Shanghai Pudong New Area People’s Hospital, Shanghai, 201299, P.R. China.
Yangui Wang Department of General Practice, Shanghai Pudong New Area People’s Hospital, Shanghai, 201299, P.R. China.
Haixia Liu Dept. of Geriatric, Shanghai Fourth People’s Hospital affiliated to Tongji University, Shanghai, 200081, P.R. China.
Tao Wang Department of General Practice, Shanghai Pudong New Area People’s Hospital, Shanghai, 201299, P.R. China.
Yue Zhao Department of Cardiology, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, 200090, P.R. China.
Yao Li Department of General Practice, Shanghai Pudong New Area People’s Hospital, Shanghai, 201299, P.R. China.; Shanghai Pudong New Area People’s Hospital, 490 Chuanhuan South Road, Shanghai, 201299, P.R. China.
Abstract
Objective: To compare the eficacy of losartan potassium (LP) and benazepril in the treatment of hypertensive patients with insulin resistance (IR). Methods: This is a retrospective analysis of the clinical data of 155 hypertensive patients with IR admitted to Shanghai Pudong New Area People's Hospital from March 2021 to March 2023. Of these 76 received LP treatment (LP group), and 79 received benazepril treatment (benazepril group). Blood pressure levels, blood glucose and insulin levels, treatment eficacy, and incidence of adverse reactions before and after the treatment in both groups were compared. Results: After the treatment, diastolic and systolic blood pressure in the two groups significantly decreased compared to pre-treatment levels (P0.05). After the treatment, levels of fasting plasma glucose (FPG), 2-hours plasma glucose (2hPG), fasting insulin (FINS), 2-hours insulin (2hINS), and insulin sensitivity index (ISI) in both groups significantly decreased compared to pre-treatment levels (P0.05). There was no significant diference in the total eficacy and the incidence of adverse reactions between the two groups (P>0.05). Conclusions: The eficacy of LP and benazepril in treating hypertension with IR is equivalent. Both are safe and can efectively lower blood sugar and insulin levels, alleviate IR, and lower blood pressure.
Publication Details
Page(s) 1608-1612
Published Journal: Pakistan Journal of Medical Sciences, Volume: 40, Issue: 8, Year: 2024

Request the full text from PASTIC

Keywords
Insulin resistance, Hypertensive, Benazepril, Losartan potassium
References
Kong DX,Xiao YX,Zhang ZX,Liu YB,Diabetes. Pak J Med Sci YB .2020 .Study on the Correlation between Metabolism, Insulin Sensitivity and progressive weight loss change in Type-. , 10(7) : 3027-1528.
Majid H,Masood Q,Khan AH .2017 .Homeostatic Model Assessment for Insulin Resistance (HOMA-IR): A Better Marker for Evaluating Insulin Resistance than Fasting Insulin in Women with Polycystic Ovarian Syndrome. J Coll Physicians Surg Pak, 27(3) : 123-126.
Fatima F,Ahsan N,Nasim A,Alam F .2020 .Association of fetuin-A with dyslipidemia and insulin resistance in type-II Diabetics of Pakistani population. Pak J Med Sci, 10(2) : 1106-68.
Khan SH,Fazal N,Ijaz A,Manzoor SM,Asif N,Rafi T .2017 .Insulin Resistance and Glucose Levels in Subjects with Subclinical Hypothyroidism. J Coll Physicians Surg Pak, 27(6) : 329-333.
Fritz J,Brozek W,Concin H,Nagel G,Kerschbaum J,Lhotta K,Hyperuricemia K .2022 .The Association of Excess Body Weight with Risk of ESKD Is Mediated Through Insulin Resistance. J Am Soc Nephrol, 10(7) : 1377-1389.
Sasaki N,Maeda R,Ozono R,Yoshimura K,Nakano Y,Higashi Y. .2022 .Adipose tissue insulin resistance predicts the incidence of hypertension: The Hiroshima Study on Glucose Metabolism and Cardiovascular Diseases. Hypertens Res, 10(11) : 1763-1771.
Wang R,Bai Z,Zhang D,Zhang R,Yang J,Yin C .2022 .Mediating effects of insulin resistance on the development of hypertension associated with elevated serum uric acid: A prospective cohort study. J Hum Hypertens, 10(8) : 760-766.
Lin CH,Wei JN,Fan KC,Fang CT,Wu WC,Yang CY .2021 .Different cutoffs of hypertension, risk of incident diabetes and progression of insulin resistance: A prospective cohort study. J Formos Med Assoc, 02(1 Pt 1) : 193-201.
LM Burrell .1997 .A risk-benefit assessment of losartan potassium in the treatment of hypertension. Drug Saf, 10(1) : 56-65.
Gradman AH,Arcuri KE,Goldberg AI,Ikeda LS,Nelson EB,Snavely DB .1995 .A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension, 25(6) : 1345-1350.
Dahal SS,Gupta M.,Benazepril M. .2023 .. StatPearls Publishing; January 16, : .
Unger T,Borghi C,Charchar F,Khan NA,Poulter NR,Prabhakaran D .2020 .. International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension, 10(6) : 1334-1357.
Bloomgarden ZT .2003 .American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome. Diabetes Care, 10(3) : 933-939.
Xiao WY,Ning N,Tan MH,Jiang XS,Zhou L,Liu L .2015 .Effects of antihypertensive drugs losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension combined with isolated impaired fasting glucose. Hypertens Res, 10(5) : 321-326.
Da Silva AA,Do Carmo JM,Li X,Wang Z,Mouton AJ,Hall JE .2020 .Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited. Can J Cardiol, 02(5) : 671-682.
Yang Z,Gong H,Kan F,Ji N. .2023 .Association between the triglyceride glucose (TyG) index and the risk of acute kidney injury in critically ill patients with heart failure: analysis of the MIMICIV database. Cardiovasc Diabetol, 10(1) : 232.
Zhang Y,Li L,Shi C. .2020 .Clinical Observation on Tiaoya Mixture in the Treatment of Essential Hypertension with Insulin Resistance - CNKI. , 11 : 2779-113.
Li A,Qu R,Zhong J. .2019 .Clinical study of benazepril combined with pioglitazone metformin tablets in the treatment of metabolic syndrome with hypertension. J Mod Med Heal, 07(7) : 5519-995.
Mancusi C,Izzo R,di Gioia G,Losi MA,Barbato E,Morisco C .2020 .Insulin Resistance the Hinge Between Hypertension and Type 2 Diabetes. , 10(6) : 515-526.
Nouri-Vaskeh M,Kalami N,Zand R,Soroureddin Z,Varshochi M,Ansarin K .2021 .Comparison of losartan and amlodipine effects on the outcomes of patient with COVID-19 and primary hypertension: A randomised clinical trial. Int J Clin Pract, 10(6) : .
Lee JW,Choi E,Son JW,Youn YJ,Ahn SG,Ahn MS .2020 .Comparison of Blood Pressure Variability Between Losartan and Amlodipine in Essential Hypertension (COMPAS-BPV). Am J Hypertens, 10(8) : 748-755.
Shi J,Liang D,Pan Y,Zhang S,He M,Zhang H .2019 .Effects of doxazosin mesylate versus nifedipine on blood pressure variability in hypertensive patients: a randomized crossover study (SIMILAR). , 10(5) : 252-258.
Laakso M,Karjalainen L,Lempiäinen-Kuosa P L .1996 .Effects of losartan on insulin sensitivity in hypertensive subjects. Hypertension, 28(3) : 392-396.
Bharati SM,Singh N. .2016 .Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients. J Pharmacol Pharmacother, 10(2) : 0976-500X.
0

Citations

0

Downloads

92

Views